Ken Ofusa

Dr. Ken Ofusa


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
MKMasamitsu Konno
Masamitsu Konno
JKJun Koseki
Jun Koseki
AAAyumu Asai
Ayumu Asai
AYAkira Yamagata
Akira Yamagata
TSTeppei Shimamura
Teppei Shimamura
HIHideshi Ishii
Hideshi Ishii
The biological significance of micro (mi)RNAs has traditionally been evaluated according to their RNA expression levels based on the assumption that miRNAs recognize and regulate their targets in an unvarying fashion. Here we show that a fraction of mature miRNAs including miR-17-5p, -21-5p, and -200c-3p and let-7a-5p harbor methyl marks that potentially alter their stability and target recognition. Importantly, methylation of these miRNAs was significantly increased in cancer tissues as compared to paired normal tissues. Furthermore, miR-17-5p methylation level in serum samples distinguished early pancreatic cancer patients from healthy controls with extremely high sensitivity and specificity. These findings provide a basis for diagnostic strategies for early-stage cancer and add a dimension to our understanding of miRNA biology.

Verified
Journal Article
Open access
PDF file
AAAyumu Asai
Ayumu Asai
MKMasamitsu Konno
Masamitsu Konno
MOMiyuki Ozaki
Miyuki Ozaki
COChihiro Otsuka
Chihiro Otsuka
AVAndrea Vecchione
Andrea Vecchione
HIHideshi Ishii
Hideshi Ishii
Since the infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was reported in China during December 2019, the coronavirus disease 2019 (COVID-19) has spread on a global scale, causing the World Health Organization (WHO) to issue a warning. While novel vaccines and drugs that target SARS-CoV-2 are under development, this review provides information on therapeutics which are under clinical trials or are proposed to antagonize SARS-CoV-2. Based on the information gained from the responses to other RNA coronaviruses, including the strains that cause severe acute respiratory syndrome (SARS)-coronaviruses and Middle East respiratory syndrome (MERS), drug repurposing might be a viable strategy. Since several antiviral therapies can inhibit viral replication cycles or relieve symptoms, mechanisms unique to RNA viruses will be important for the clinical development of antivirals against SARS-CoV-2. Given that several currently marketed drugs may be efficient therapeutic agents for severe COVID-19 cases, they may be beneficial for future viral pandemics and other infections caused by RNA viruses when standard treatments are unavailable.

10 June 2020 in Diagnostics
Verified
Journal Article
Open access
PDF file
MKMasamitsu Konno
Masamitsu Konno
AAAyumu Asai
Ayumu Asai
TKToru Kitagawa
Toru Kitagawa
MYMasami Yabumoto
Masami Yabumoto
KOKen Ofusa
Ken Ofusa
HIHideshi Ishii
Hideshi Ishii
Since the 1980s, molecular biology has been used to investigate medical field mechanisms that still require the use of crude biological materials in order to achieve their necessary goals. Transcription factor-induced pluripotent stem cells are used in regenerative medicine to screen drugs and to support lost tissues. However, these cells insufficiently reconstruct whole organs and require various intact cells, such as damaged livers and diabetic pancreases. For efficient gene transfer in medical use, virally mediated gene transfers are used, although immunogenic issues are investigated. To obtain efficient detective and diagnostic power in intractable diseases, biological tools such as roundworms and zebrafish have been found to be useful for high-throughput screening (HST) and diagnosis. Taken together, this biological approach will help to fill the gaps between medical needs and novel innovations in the field of medicine.

13 July 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
MNMika Nakayama
Mika Nakayama
YOYuki Ozato
Yuki Ozato
YTYoshiko Tsuji
Yoshiko Tsuji
YAYasuko Arao
Yasuko Arao
COChihiro Otsuka
Chihiro Otsuka
HIHideshi Ishii
Hideshi Ishii
Inflammatory bowel disease (IBD) is a chronic inflammatory disorder characterized by damage to the intestinal mucosa, which is caused by a combination of factors. These include genetic and epigenetic alterations, environmental influence, microorganism interactions, and immune conditions. Some populations with IBD show a cancer-prone phenotype. Recent studies have provided insight into the involvement of RNA modifications in the specific pathogenesis of IBD through regulation of RNA biology in epithelial and immune cells. Studies of several RNA modification-targeting reagents have shown preferable outcomes in patients with colitis. Here, we note a new awareness of RNA modification in the targeting of IBD and related diseases, which will contribute to early diagnosis, disease monitoring, and possible control by innovative therapeutic approaches.

12 October 2021 in Cancers
Verified
Journal Article
Open access
PDF file
STShotaro Tatekawa
Shotaro Tatekawa
KOKen Ofusa
Ken Ofusa
RCRyota Chijimatsu
Ryota Chijimatsu
AVAndrea Vecchione
Andrea Vecchione
KTKeisuke Tamari
Keisuke Tamari
HIHideshi Ishii
Hideshi Ishii
As cancer is a genetic disease, methylation defines a biologically malignant phenotype of cancer in the association of one-carbon metabolism-dependent S-adenosylmethionine (SAM) as a methyl donor in each cell. Methylated substances are involved in intracellular metabolism, but via intercellular communication, some of these can also be secreted to affect other substances. Although metabolic analysis at the single-cell level remains challenging, studying the “methylosystem” (i.e., the intercellular and intracellular communications of upstream regulatory factors and/or downstream effectors that affect the epigenetic mechanism involving the transfer of a methyl group from SAM onto the specific positions of nucleotides or other metabolites in the tumor microenvironment) and tracking these metabolic products are important research tasks for understanding spatial heterogeneity. Here, we discuss and highlight the involvement of RNA and nicotinamide, recently emerged targets, in SAM-producing one-carbon metabolism in cancer cells, cancer-associated fibroblasts, and immune cells. Their significance and implications will contribute to the discovery of efficient methods for the diagnosis of and therapeutic approaches to human cancer.

9 July 2020 in Cells
Verified
Journal Article
Open access
PDF file
YTYu Takeda
Yu Takeda
SKShogo Kobayashi
Shogo Kobayashi
MKMasatoshi Kitakaze
Masatoshi Kitakaze
DYDaisaku Yamada
Daisaku Yamada
HAHirofumi Akita
Hirofumi Akita
HIHideshi Ishii
Hideshi Ishii
Exosomes (EXs), a type of extracellular vesicles secreted from various cells and especially cancer cells, mesenchymal cells, macrophages and other cells in the tumor microenvironment (TME), are involved in biologically malignant behaviors of cancers. Recent studies have revealed that EXs contain microRNAs on their inside and express proteins and glycolipids on their outsides, every component of which plays a role in the transmission of genetic and/or epigenetic information in cell-to-cell communications. It is also known that miRNAs are involved in the signal transduction. Thus, EXs may be useful for monitoring the TME of tumor tissues and the invasion and metastasis, processes that are associated with patient survival. Because several solid tumors secrete immune checkpoint proteins, including programmed cell death-ligand 1, the EX-mediated mechanisms are suggested to be potent targets for monitoring patients. Therefore, a companion therapeutic approach against cancer metastasis to distant organs is proposed when surgical removal of the primary tumor is performed. However, EXs and immune checkpoint mechanisms in pancreatic cancer are not fully understood, we provide an update on the recent advances in this field and evidence that EXs will be useful for maximizing patient benefit in precision medicine.